What You Should Know:
– OncoHost, a company pioneering personalized medicine approaches for better patient outcomes, announced a collaborative research study with Dana-Farber Cancer Institute, a leading cancer treatment and research center.
– The project aims…
Continue Reading
We have developed a digital twin-based CKD identification and prediction model that leverages generalized metabolic fluxes (GMF) for patients with Type 2 Diabetes Mellitus (T2DM). GMF digital twins utilized basic clinical and physiological biomarkers…
Continue Reading
A mobile application used to assess sports-related head and brain injuries is now being tested for detecting and monitoring neurological disorders. BrainEye’s mobile test is now being studied in clinical trials at The Alfred Hospital…
Continue Reading
Background: Postpartum depression (PPD) poses a significant maternal health challenge. The current approach to detecting PPD relies on in-person postpartum visits, which contributes to underdiagnosis. Furthermore, recognizing PPD symptoms can be challenging. Therefore, we…
Continue Reading
Neural and psychological AI company NeuroBrave has partnered with Sourasky Medical Center’s Functional Neurology Unit in Tel Aviv, Israel to accelerate research into complex neurological conditions. The collaboration seeks to utilize AI for real-time translation…
Continue Reading
What You Should Know:
– When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to…
Continue Reading
What You Should Know:
– Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA.
– The investment brings Nucleai’s total funding to $60M…
Continue Reading
What You Should Know:
Viome, a leading innovator of health technology and personalized health solutions, is partnering with Henry Schein to provide better access to Viome’s Oral Health Pro™ With CancerDetect™.Viome’s laboratory-developed test helps detect early…
Continue Reading
Progress in sequencing technologies and clinical experiments has revolutionized immunotherapy on solid and hematologic malignancies. However, the benefits of immunotherapy are limited to specific patient subsets, posing challenges for broader application. To improve its…
Continue Reading
